Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Trends Supporting 27.9% CAGR Growth Through 2030
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The market size for AI brain MRI lesion detection has experienced rapid expansion over recent years. Its valuation is projected to increase from $1.00 billion in 2025 to $1.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. Historically, this growth has been driven by factors such as the greater utilization of MRI in neurology, the increasing acceptance of digital radiology, the rising occurrence of brain tumors and stroke, expanding investments by hospitals in imaging systems, and a growing demand for prompt disease diagnosis.
The AI brain MRI lesion detection market is projected to experience substantial growth over the coming years. This market is forecast to reach $2.69 billion in 2030, advancing at a compound annual growth rate (CAGR) of 21.9%. This anticipated growth, along with major trends during the forecast period, is primarily attributed to an escalating demand for AI-enabled diagnostics, increased governmental backing for AI within healthcare, the expanding adoption of cloud medical imaging, greater integration of AI with PACS systems, and rising investment in tele-radiology solutions.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Growth Factors Behind Sustained Expansion
The rising occurrence of neurological disorders is anticipated to fuel the expansion of the artificial intelligence (AI) brain MRI lesion detection market in the future. These conditions are medical ailments impacting the brain, spinal cord, and nerves, thereby disturbing typical nervous system operations and resulting in impairments in movement, cognition, sensation, behavior, or overall bodily control. The growing incidence of neurological disorders stems from detrimental lifestyle practices, such as inadequate diet, lack of physical activity, smoking, excessive alcohol intake, and persistent stress. AI brain MRI lesion detection offers assistance to individuals suffering from neurological disorders by allowing for quicker and more precise identification of brain abnormalities, which aids in early diagnosis, tailored treatment strategies, and enhanced patient results. For example, in April 2024, as per the National Institutes of Health (NIH), a leading US government biomedical research institution, approximately 6.9 million Americans aged 65 and above are presently afflicted with Alzheimer’s dementia, a number predicted to nearly double to 13.8 million by 2060. Consequently, the increasing prevalence of neurological disorders is a key driver for the artificial intelligence (AI) brain MRI lesion detection market.
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Segment Breakdown: Which Categories Lead On Revenue?
The artificial intelligence (AI) brain magnetic resonance imaging (mri) lesion detection market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Lesion Type: Tumor Lesions, Vascular Lesions, Demyelinating Lesions, Traumatic Lesions, Other Lesion Types
3) By Modality: 3D MRI, 2D MRI, Other Modalitys
4) By Application: Tumor Detection, Multiple Sclerosis, Stroke, Traumatic Brain Injury, Other Applications
5) By End-User: Hospitals, Diagnostic Imaging Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Deep Learning Detection Software, Image Processing Software, Clinical Decision Support Software, Diagnostic Reporting Software, Annotation and Labeling Software
2) By Hardware: Magnetic Resonance Imaging Scanners, Graphics Processing Units, Edge Computing Devices, Image Acquisition Systems
3) By Services: Installation And Integration Services, Model Training And Customization Services, Maintenance And Support Services, Data Annotation And Validation Services
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Industry Trends Fueling Future Revenue Growth
Leading companies in the artificial intelligence (AI) brain MRI lesion detection market are prioritizing the creation of advanced solutions, such as AI-driven contrast enhancement systems, to improve the early identification of subtle brain abnormalities and elevate diagnostic precision. These AI-powered systems employ sophisticated algorithms to enhance lesion visibility on contrast-enhanced MRI scans, consequently improving lesion-to-brain and contrast-to-noise ratios without modifying standard acquisition protocols. For example, in October 2024, Bracco Diagnostics, a US-based medical imaging company, and Subtle Medical, a US-based AI healthcare company, introduced AiMIFY software. This AI-based brain MRI enhancement tool increases contrast enhancement up to two times compared with standard gadolinium-based imaging and improves the clarity of lesions while preserving existing scanning workflows. This launch signifies a substantial technological step forward, integrating AI with conventional imaging and linking advanced computational analysis with clinical radiology practice. It delivers a scalable, efficient method for strengthening diagnostic confidence and enabling early lesion detection in neurological imaging.
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Key Participants And Competitive Landscape
Major companies operating in the artificial intelligence (AI) brain magnetic resonance imaging (mri) lesion detection market are Aidoc Medical Ltd., RapidAI Inc., Annalise.ai Pty Ltd., Quibim S.L., Olea Medical Imaging SAS, DeepTek.ai Inc., Image Analysis Group Ltd., Subtle Medical Inc., Gleamer SAS, Raidium Ltd., Invicro LLC, CorTechs.ai Inc., Omniscient Neurotechnology Inc., NeoSoma Inc., Oxipit Ltd., Cerebriu Inc., BrainReader ApS, MedImaging AI Solutions Ltd., NeuroVision Imaging Inc., NeuroQuant Analytics Inc.
View The Full Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Report:
Artificial Intelligence (AI) Brain Magnetic Resonance Imaging (MRI) Lesion Detection Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the AI brain MRI lesion detection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) brain magnetic resonance imaging (mri) lesion detection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model